Effects of triptolide on proliferation and apoptosis of Jurkat cell line in acute T lymphocytic leukemia.
- Author:
Gen-Hong YAO
1
;
Jian-Feng LUAN
;
Dong YE
;
Jing-Mei YAN
;
Qian-Hong LEI
;
Pei-Yuan ZHU
;
Jie JIN
Author Information
1. Department of Transfusion, Postdoctoral Work Station, Nanjing General Hospital of Nanjing Military Area, Nanjing 210002, Jiangsu Province, China. yaogenhong@yahoo.com
- Publication Type:Journal Article
- MeSH:
Antineoplastic Agents, Alkylating;
pharmacology;
Apoptosis;
drug effects;
Cell Proliferation;
drug effects;
Diterpenes;
pharmacology;
Epoxy Compounds;
pharmacology;
Humans;
Jurkat Cells;
Phenanthrenes;
pharmacology
- From:
Journal of Experimental Hematology
2008;16(3):506-509
- CountryChina
- Language:Chinese
-
Abstract:
The aim of this study was to investigate the anti-proliferation and pro-apoptosis of triptolide on Jurkat cell line in acute T lymphocytic leukemia. The Jurkat cells were treated with various concentrations of triptolide (0, 1, 2, 4, 8, 16 microg/L) for 12 hours. The inhibitory ratio was measured by Cell Counting Kit-8 assay. The effects of triptolide on apoptosis of Jurkat cells were determined by DNA fragmentation (DNA ladder), Hoechst 33258, PI and Annexin V-FITC/PI double staining. The results demonstrated that triptolide inhibited the proliferation of Jurket cells. The 50% inhibitory concentration (IC(50)) was 4.0 microg/L. Chromatin condensation in the cells treated with triptolide could be seen by light microscopy. DNA electrophoresis showed evidence of nuclear fragmentation (DNA ladder). The hypoploid (sub-G(1)) population was increased after treatment with triptolide. The translocation of phosphatidylserine at the outer surface of the cell plasma membrane could be induced by triptolide. After treatment with triptolide for 12 hours, the rates of apoptotic cells were significantly increased. Moreover, these pro-apoptosis effects were in time-dependent manner. It is concluded that triptolide can inhibit the proliferation and induce the apoptosis of Jurkat cells. This study provides experimental basis for clinical use of triptolide in leukemia therapy.
